Scale offers the possibility of identifying adherence to lifestyle interventions in patients with non-alcoholic fatty liver disease

doi:10.3748/wjg.v30.i25.3179

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 30, Issue 25

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2156)

All Articles published online

The chart showing PDF series, HTML series.

Item

Count

PDF

122

HTML

1205

Sum=1327

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

149

Download

559

Sum=708

Jul 7, 2024 (publication date) through Oct 30, 2025

Times Cited of This Article

Times Cited (1)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Letter to the Editor

World J Gastroenterol. Jul 7, 2024; 30(25): 3179-3181
Published online Jul 7, 2024. doi: 10.3748/wjg.v30.i25.3179

Scale offers the possibility of identifying adherence to lifestyle interventions in patients with non-alcoholic fatty liver disease

Cen-Qin Liu, Bing Hu

Cen-Qin Liu, Department of Gastroenterology and Hepatology, West China Hospital, Sichuan University, Chengdu 610041, Sichuan Province, China

Bing Hu, Department of Gastroenterology and Hepatology/Medical Engineering Integration Laboratory of Digestive Endoscopy, West China Hospital, Sichuan University, Chengdu 610041, Sichuan Province, China

Author contributions: Liu CQ and Hu B co-authored and revised the manuscript; and both authors have read and approved the final manuscript.

Conflict-of-interest statement: The authors declare no conflicts of interest.

Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/

Corresponding author: Bing Hu, MD, Editor-in-Chief, Professor, Department of Gastroenterology and Hepatology/Medical Engineering Integration Laboratory of Digestive Endoscopy, West China Hospital, Sichuan University, No. 37 Guoxue Alley, Chengdu 610041, Sichuan Province, China. hubing@wchscu.edu.cn

Received: March 18, 2024
Revised: May 27, 2024
Accepted: June 17, 2024
Published online: July 7, 2024
Processing time: 105 Days and 0.2 Hours

Core Tip

Core Tip: Nonalcoholic fatty liver disease is the most common chronic liver disorder and the leading cause of cirrhosis and hepatocellular carcinoma. In this editorial, we aim to highlight the importance of a scale that can evaluate compliance with lifestyle interventions and guide the choice of targeted therapy. However, the universal applicability of the scale and the corresponding personalized treatment need to be carefully considered based on patients’ characteristics and doctors’ expertise.